Association of genetic polymorphisms with response to bevacizumab for neovascular age-related macular degeneration in the Chinese population.
about
Genetic risk, ethnic variations and pharmacogenetic biomarkers in age-related macular degeneration and polypoidal choroidal vasculopathyAssociation between polymorphism rs11200638 in the HTRA1 gene and the response to anti-VEGF treatment of exudative AMD: a meta-analysis.Pharmacogenetic associations with long-term response to anti-vascular endothelial growth factor treatment in neovascular AMD patientsBevacizumab treatment for neovascular age-related macular degeneration in the setting of a clinic: "real life" long-term outcomeEffect of High-Density Lipoprotein Metabolic Pathway Gene Variations and Risk Factors on Neovascular Age-Related Macular Degeneration and Polypoidal Choroidal Vasculopathy in China.Predictors of visual response to intravitreal bevacizumab for treatment of neovascular age-related macular degenerationPharmacogenetics of the treatment response of age-related macular degeneration with ranibizumab and bevacizumab.Association of the polymorphism Y402H in the CFH gene with response to anti-VEGF treatment in age-related macular degeneration: a systematic review and meta-analysis.Y402H polymorphism in complement factor H and age-related macular degeneration in the Tunisian population.A prospective multicenter study on genome wide associations to ranibizumab treatment outcome for age-related macular degeneration.Incidence and risk factors of retreatment after three-monthly aflibercept therapy for exudative age-related macular degeneration.Fighting blinding fundus diseases: China on the way!C-reactive protein and complement factor H polymorphism interaction in advanced exudative age-related macular degeneration.Exploring the Use of Molecular Biomarkers for Precision Medicine in Age-Related Macular Degeneration.Predicting Non-response to Ranibizumab in Patients with Neovascular Age-related Macular Degeneration
P2860
Q33645265-68FF6660-1707-4C74-B70C-03C030D7327FQ33823849-D969AFAF-7CFF-440A-8FF2-B2D70795EDF0Q34781693-C327C19F-2FC4-4088-B9F6-5B826856C4C2Q35503206-DB39E200-B128-4878-AFEE-02DDDE0459BBQ35857083-4B2317F5-3054-4DA4-A68F-BB66EA458A8FQ37166529-9B85959C-2FCF-4508-88F2-09EFD8A7776DQ38134807-052D7BDD-59C8-4530-A374-82A77F8C98BCQ38827325-A4DA3D99-1EF9-4AD1-97D1-7965278EC465Q39039293-22E3E34F-8E9E-4985-B89C-58A61BE2682FQ41504310-D79C8F89-3F98-45D0-B94C-F9FCEB759DB5Q42136459-3BAFA4EB-A8E5-4567-BC44-7B514F1FD1BCQ44305599-77251E9F-E9E6-4995-AADB-DB080D79FF93Q50132287-137CC296-6D32-491C-BC52-308772CEC37BQ52559837-3AB35323-94B9-4EDC-A5B2-38B6A26697B5Q57253241-EF4F872D-7148-4C9A-AE5E-AC974A3B09A4
P2860
Association of genetic polymorphisms with response to bevacizumab for neovascular age-related macular degeneration in the Chinese population.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Association of genetic polymor ...... ion in the Chinese population.
@en
Association of genetic polymor ...... ion in the Chinese population.
@nl
type
label
Association of genetic polymor ...... ion in the Chinese population.
@en
Association of genetic polymor ...... ion in the Chinese population.
@nl
prefLabel
Association of genetic polymor ...... ion in the Chinese population.
@en
Association of genetic polymor ...... ion in the Chinese population.
@nl
P2093
P2860
P356
P1433
P1476
Association of genetic polymor ...... ion in the Chinese population.
@en
P2093
Dafang Chen
Wenzhen Yu
Xiaoxin Li
Xueying Qin
Yonghua Hu
P2860
P304
P356
10.2217/PGS.12.53
P577
2012-05-01T00:00:00Z